3[3]Todoki T,Usui M,Takakura K.Treatment of severe intra-ventricular hemorrhage by intraventricular infusion of urokinase[J].J Neurosury,1991,74 (1):81～86
4崔磊 高霞 郑秀杰.中风患者超早期康复护理指导[J].医药前沿,2011,.
5Mayfrank, L Lippitz B Mayfrank L,Groth M. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir (Wien),1993,122(1 -2) :32 -38.
6Todo T, Usui M,Takakura K. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neur Osutg, 1991 Jan,74(1) :81 -86.
7Angelopouos M, Gupta SR, Axat Kia B. Primary intraventricular hemorrhage in adults clinical features, risk factors, and outcome. Surg Neurol,1995,44(5):4334.
8Broderick JP,Adams HP Jr,Barsan W,et al. Guide lines for the management of spontaneous intracerebral hemorrhage. Stroke, 1999, 30 ( 4 ) :905-915.
